Medical Collagen Market Size & Share Report 2022, 2028
The medical collagen market is expected to reach US$ 957.4 million by 2028 from US$ 593.7 million in 2020; it is estimated to grow at a CAGR of 6.2% from 2021 to 2028.
Collagen is the most abundantly found protein in human body. It occurs mostly in fibrous tissues such as ligaments, skin, tendons, cornea, blood vessels, bones, cartilages, and intervertebral disc. Medical collagen is a biocompatible material with low immunogenicity. Collagen has good hemostatic properties and facilitates wound healing. It is used in cell cultures as it supports cell proliferation in lattice structures and cell binding domain. Medical collagen is widely used in applications such as wound healing, tissue engineering, reconstructive surgeries, bone grafts, and cosmetic surgeries. The growth of the medical collagen market is attributed to the factors such as the rising applications of collagen in the medical industry, and growing FDA approvals and product launches. However, product recalls hinder the market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Medical Collagen Market: Strategic Insights
Medical Collagen Market
-
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cagr.png)
CAGR (2020 - 2028)
6.2%
-
Market Size 2020
US$ 593.7 Million
-
Market Size 2028
US$ 957.4 Million
Market Dynamics
GROWTH DRIVERS
- XXXXXXX
- XXXXXXX
- XXXXXXX
FUTURE TRENDS
- XXXXXXX
- XXXXXXX
- XXXXXXX
OPPORTUNITIES
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- DSM
- INTEGRA LIFESCIENCES CORPORATION
- COLLAGEN MATRIX, INC.
- ENCOLL
- COLLAGEN SOLUTIONS PLC
- INNOCOLL
- SYMATESE
- GELITA AG
- COLLPLANT BIOTECHNOLOGIES LTD
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Source
- Bovine
- Porcine
- Others
Product
- Gelatine
- Hydrolysed Collagen
- Native Collagen
- Others
Application
- Wound Care
- Bone Grafts
- Tissue Scaffolds
- Cartilage Repair
- Haemostats
- Diagnostics
- Vascular Grafts
- Others
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Medical Collagen Market: Strategic Insights
-
CAGR (2020 - 2028)6.2% -
Market Size 2020
US$ 593.7 Million -
Market Size 2028
US$ 957.4 Million
![](https://www.theinsightpartners.com/assets/images/rd_int_img/tip-logo.jpg)
Market Dynamics
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- DSM
- INTEGRA LIFESCIENCES CORPORATION
- COLLAGEN MATRIX, INC.
- ENCOLL
- COLLAGEN SOLUTIONS PLC
- INNOCOLL
- SYMATESE
- GELITA AG
- COLLPLANT BIOTECHNOLOGIES LTD
Regional Overview
![](https://www.theinsightpartners.com/assets/images/rd_int_img/ig-regional.png)
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_danger.png)
- Bovine
- Porcine
- Others
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_warning.png)
- Gelatine
- Hydrolysed Collagen
- Native Collagen
- Others
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_primary.png)
- Wound Care
- Bone Grafts
- Tissue Scaffolds
- Cartilage Repair
- Haemostats
- Diagnostics
- Vascular Grafts
- Others
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Market Insights
Rising Applications of Collagen in Medical Industry
Collagen is the protein found in connective tissues of the body. It is the most abundant protein found in the mammals, which makes up around 25%–35% of the whole-body protein content. As collagen is weakly antigenic and biodegradable, it has excellent biocompatibility. Thus, making it a primary resource in medical applications.
The cardiac extracellular matrix (ECM) consists of fibrillar collagen that provides a means of force transmission, preserves myocardial integrity, and supports myocyte geometry. Several studies have proved that consuming collagen supplements will help in reducing the risk of heart-related conditions.
Collagen is one of the key constituents in cosmetic formulations as it has moisturizing, regenerating, and film-forming properties. Collagen has excellent ability to bind water that helps in maintaining proper water content in the skin throughout the day, which makes the skin moisturized and softened. Moreover, collagen fillers are widely used in aesthetic medicine. The subcutaneous injection of soluble collagen enhances the quality and density of the skin, thereby repairing its dermatological defects.
Collagen-based biomaterials have a wide range of applications in vivo and in vitro. Collagen has been widely used to develop synthetic bone graft substitutes of spine, extremities, and dental. Further, collagen scaffolds are developed to mimic and regenerate native tissues and are being rapidly adopted for cartilage repair.
Collagen is naturally involved in the wound-healing process and the use of collagen-based wound dressings offers several advantages for acute and chronic wound closure. Additionally, collagen dressings can control the moisture of the wound, by either absorbing or providing moisture. Thus, collagen is widely used in dressings, particles, and flowable scaffolds to treat acute and chronic wounds.
These wide range of applications of collagen in the medical industry favors the growth of the market.
Product-based Insights
The medical collagen market, by source, is segmented into bovine, porcine, and others. The bovine segment held the largest share of the market in 2020, and it is anticipated to register the highest CAGR in the market during the forecast period.
Product-based Insights
Based on product, the medical collagen market is segmented into gelatine, hydrolysed collagen, native collagen, and others. The gelatine segment held the largest market share in 2020 and is anticipated to register the highest CAGR in the market during the forecast period.
Application-based Insights
Based on application, the medical collagen market is segmented into haemostats, vascular grafts, tissue scaffolds, cartilage repair, wound care, bone grafts, diagnostics, and other. The wound care segment held the largest market share in 2020, and the bone grafts segment is estimated to register the highest CAGR in the market during the forecast period.
Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Collaboration is one of the major strategies adopted by the medical collagen market players to enlarge customer base worldwide, which, in turn, permits them to maintain their brand name globally.
Medical Collagen Market Report Scope
Report Attribute
Details
Market size in 2020
US$ 593.7 Million
Market Size by 2028
US$ 957.4 Million
Global CAGR (2020 - 2028)
6.2%
Historical Data
2018-2019
Forecast period
2021-2028
Segments Covered
By Source - Bovine
- Porcine
- Others
By Product - Gelatine
- Hydrolysed Collagen
- Native Collagen
- Others
By Application - Wound Care
- Bone Grafts
- Tissue Scaffolds
- Cartilage Repair
- Haemostats
- Diagnostics
- Vascular Grafts
- Others
Regions and Countries Covered
North America - US
- Canada
- Mexico
Europe - UK
- Germany
- France
- Russia
- Italy
- Rest of Europe
Asia-Pacific - China
- India
- Japan
- Australia
- Rest of Asia-Pacific
South and Central America - Brazil
- Argentina
- Rest of South and Central America
Middle East and Africa - South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
Market leaders and key company profiles
DSM
INTEGRA LIFESCIENCES CORPORATION
COLLAGEN MATRIX, INC.
ENCOLL
COLLAGEN SOLUTIONS PLC
INNOCOLL
SYMATESE
GELITA AG
COLLPLANT BIOTECHNOLOGIES LTD
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Attribute | Details |
---|---|
Market size in 2020 | US$ 593.7 Million |
Market Size by 2028 | US$ 957.4 Million |
Global CAGR (2020 - 2028) | 6.2% |
Historical Data | 2018-2019 |
Forecast period | 2021-2028 |
Segments Covered |
By Source
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Medical Collagen Market – by Source
- Bovine
- Porcine
- Others
Medical Collagen Market – by Product
- Gelatine
- Hydrolysed Collagen
- Native Collagen
- Others
Medical Collagen Market – by Application
- Wound Care
- Bone Grafts
- Tissue Scaffolds
- Cartilage Repair
- Haemostats
- Diagnostics
- Vascular Grafts
- Other
Medical Collagen Market – by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
South and Central America
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- DSM
- Integra Lifesciences Corporation
- Collagen Matrix Inc.
- Encoll
- Collagen Solutions Plc
- Innocoll
- Symatese
- Gelita AG
- Collplant Biotechnologies Ltd
- Croda Interntional PLC.
![Report Coverage](https://www.theinsightpartners.com/assets/rdimages/report_coverage.png)
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
![Segment Covered](https://www.theinsightpartners.com/assets/rdimages/segment_covered.png)
Segment Covered
Source , Product , and Application
![Regional Scope](https://www.theinsightpartners.com/assets/rdimages/regional_scope.png)
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
![Country Scope](https://www.theinsightpartners.com/assets/rdimages/country_scope.png)
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The global medical collagen market growth is mainly attributed to factors such the rising applications of collagen in medical industry and growing FDA approvals and product launches fuel the growth of the market. However, product recalls is the major factor hindering the market growth.
The medical collagen market majorly consists of the players such as DSM, Integra Lifesciences Corporation, Collagen Matrix, Inc., Encoll, Collagen Solutions Plc, Innocoll, Symatese, Gelita Ag, Collplant Biotechnologies Ltd, and Croda Interntional PLC. among others.
Collagen is the most abundantly found protein in human body. It occurs mostly in fibrous tissues such as ligaments, skin, tendons, cornea, blood vessels, bones, cartilages, and intervertebral disc. Medical collagen is widely used in applications such as wound healing, tissue engineering, reconstructive surgeries, bone grafts, and cosmetic surgeries. It is bio-compatible material with low immunogenicity. Collagen has good hemostatic properties and facilitates wound healing. Collagen is used in cell cultures as it supports cell proliferation in lattice structures and cell binding domain. Hence collagen is widely used as a biomaterial in the medical industry. The exponential increase in number of regenerative surgeries performed on patients to treat certain forms of skin cancers, burn injuries, birth defects, and congenital diseases is primarily expected to drive the demand for medical collagen.
The List of Companies - Medical Collagen Market
- DSM
- INTEGRA LIFESCIENCES CORPORATION
- COLLAGEN MATRIX, INC.
- ENCOLL
- COLLAGEN SOLUTIONS PLC
- INNOCOLL
- SYMATESE
- GELITA AG
- COLLPLANT BIOTECHNOLOGIES LTD
- CRODA INTERNTIONAL PLC